Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001070698-11-000146
Filing Date
2011-12-19
Accepted
2011-12-16 17:52:16
Documents
5
Period of Report
2011-08-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR 10-K/A AUGUST 31, 2011 121611 raptor10ka121611.htm 10-K/A 424928
2 EXHIBIT 21.1 LIST OF SUBSIDIARIES listofsubsidiaries.htm EX-21.1 4991
3 CEO CERTIFICATION ceocertification121611.htm EX-31.1 8890
4 CFO CERTIFICATION cfocertification121611.htm EX-31.2 9190
5 CEO AND CFO CERTIFICATION ceoceocert121611.htm EX-32.1 9334
  Complete submission text file 0001070698-11-000146.txt   458649
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-K/A | Act: 34 | File No.: 000-25571 | Film No.: 111267541
SIC: 2834 Pharmaceutical Preparations